MAPK8 and prostate cancer: Furthermore, TAC can activate extracellular signal-regulated kinase 1/2 (ERK1/2), but not p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK), to mediate a prostate cancer cell response [45].